Navigation Links
PharmaPoint: Acute Coronary Syndrome - 5EU Drug Forecast and Market Analysis to 2023
Date:10/14/2014

NEW YORK, Oct. 14, 2014 /PRNewswire/ -- PharmaPoint: Acute Coronary Syndrome - 5EU Drug Forecast and Market Analysis to 2023

Summary

GlobalData estimates that the total market size for the 7MM in 2013 was $12.3bn, comprised of $5.0bn in branded drug sales (40%) and $7.3bn in generic sales (60%). GlobalData expects that the ACS drug market will grow at a CAGR of 13.4% over the ten year forecast period, resulting in a market value of $43.4bn by 2023, of which 64% will be attributed to branded drug sales ($27.7bn) and 36% to generic drug sales ($15.7bn). The current ACS market - primarily comprised of antithrombotics, antihypertensives, and statins - is flush with well-established standard-of-care therapies, many of which are generic. Therefore, the pipeline therapies that show the most promise exploit novel mechanisms of action and target orphan biochemical pathways. The ACS market will be driven by an aging population with a preponderance of lifestyle-based diseases, such as obesity, and the growing prevalence of metabolic disorders such as diabetes. The expansion of biologics into the ACS mainstream during the ten year forecast period is expected to significantly and fundamentally alter the ACS market, both medically and financially.

France represents one of the smallest in terms of overall ACS drug sales. Next to the US market, Germany commands the largest global market share for the sale of ACS drugs. Italy's contribution to global sales in both 2013 and 2023 falls in the middle of the sales distribution for the 7MM covered in this forecast. Of the 7MMs that were forecast in this report, Spain's share of global sales is the smallest for both the 2013 base year and the final forecast year of 2023. Of the markets forecast here, the UK commands the third largest market share in both the 2013 base year and in 2023.

Scope

- Overview of ACS including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
- Detailed information on the key drugs in 5EU including product description, safety and efficacy profiles as well as a SWOT analysis.
- Sales forecast for the top drugs in 5EU (the UK, France, Italy, Spain, Germany) from 2013-2023.
- Analysis of the impact of key events as well the drivers and restraints affecting the 5EU ACS market.

Reasons to buy

- Understand and capitalize by identifying products that are most likely to ensure a robust return.
- Stay ahead of the competition by understanding the changing competitive landscape for ACS.
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential.
- Make more informed business decisions from insightful and in-depth analysis of drug performance.
- Obtain sales forecast for drugs from 2013-2023 in 5EU (the UK, France, Italy, Spain, Germany).

Read the full report: http://www.reportlinker.com/p02370535-summary/view-report.html

About Reportlinker

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001 
Intl: +1 339-368-6001


'/>"/>
SOURCE Reportlinker
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. PharmaPoint: Osteoporosis - India Drug Forecast and Market Analysis to 2022
2. PharmaPoint: Osteoporosis - US Drug Forecast and Market Analysis to 2022
3. PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis to 2022
4. PharmaPoint: Multiple Sclerosis - US Drug Forecast and Market Analysis to 2022
5. PharmaPoint: Multiple Sclerosis - United Kingdom Drug Forecast and Market Analysis to 2022
6. PharmaPoint: Dry Eye Syndrome - China Drug Forecast and Market Analysis to 2022
7. PharmaPoint: Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022
8. PharmaPoint: Alzheimers Disease - China Drug Forecast and Market Analysis to 2022
9. PharmaPoint: Type 2 Diabetes - Brazil Drug Forecast and Market Analysis to 2022
10. PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022
11. PharmaPoint: Neuropathic Pain - Japan Drug Forecast and Market Analysis to 2022
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2020)... Calif. (PRWEB) , ... February 20, 2020 , ... ... anniversary as a full-service provider of compassionate, in-home senior care from trained and ... have taken a highly personalized approach to meeting every client’s unique needs, preferences ...
(Date:2/20/2020)... ... February 20, 2020 , ... PAINWeekEnd on March ... Arizona, will be a timely and relevant 2-day program providing busy clinicians and ... of chronic pain. , In 2020, paper prescriptions for certain painkillers have been ...
(Date:2/19/2020)... ... 2020 , ... Aspire Regenerative, a leader in offering therapies that restore healthy ... free weight-loss event on March 1, 2020. It will take place from 10:30 a.m. ... , During the event, physicians and pharmacists will lead an informative and insightful discussion ...
Breaking Medicine Technology:
(Date:2/14/2020)... ... February 14, 2020 , ... ScripHessco has announced the release ... guide breaks down the benefits of chiropractic care during pregnancy and how to ... is quite beneficial to the mother’s health. Seeing a chiropractor during pregnancy leads ...
(Date:2/14/2020)... ... February 14, 2020 , ... Cloudticity ... further strengthening the company’s support for healthcare organizations using Amazon Web Services (AWS). ... the resources or experience to do so,” explained Cloudticity Founder & CEO, Gerry ...
(Date:2/13/2020)... ... February 13, 2020 , ... The Root ... to achieving health equity for all Americans will unveil its new Status of ... event at the National Press Club. , The event will feature a presentation ...
(Date:2/13/2020)... ... February 13, 2020 , ... The largest fertility ... Dulles-Aldie, Fair Oaks, Fairfax, Fredericksburg, Leesburg, and Woodbridge, as well as two locations ... specialists have been named as Top Docs for Infertility by Northern Virginia Magazine. ...
(Date:2/13/2020)... (PRWEB) , ... February 13, 2020 , ... A January ... procedures that people will be discussing in 2020. It also reports on a well-documented ... surgical procedures. Dr. Jazayeri says that his patients are increasingly knowledgeable and are asking ...
Breaking Medicine News(10 mins):